Influence of Body Weight on Cost-Effectiveness of Bone Densitometry and Treatment for Osteoporosis Among Older Women and Men Without Prior Fracture

被引:0
|
作者
Schousboe, J. T. [1 ]
Taylor, B. C. [2 ]
Fink, H. A. [2 ]
Adler, R. A. [3 ]
Gourlay, M. [4 ]
Orwoll, E. S. [5 ]
Barrett-Connor, E. [6 ]
Cummings, S. R. [7 ]
Melton, L. J. [8 ]
Ensrud, K. E. [2 ]
机构
[1] Univ Minnesota, Div Hlth Policy & Management, Pk Nicollet Clin, Minneapolis, MN USA
[2] Univ Minnesota, Minneapolis VAMC, Minneapolis, MN USA
[3] Richmond VAMC, Richmond, VA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ Calif San Diego, San Diego, CA 92103 USA
[7] San Francisco Coordinating Ctr, San Francisco, CA USA
[8] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S124 / S124
页数:1
相关论文
共 50 条
  • [31] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    Osteoporosis International, 2004, 15 : 862 - 871
  • [32] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [33] Bridging the Osteoporosis Treatment Gap: Performance and Cost-Effectiveness of a Fracture Liaison Service
    Yates, Christopher J.
    Chauchard, Marie-Anne
    Liew, Danny
    Bucknill, Andrew
    Wark, John D.
    JOURNAL OF CLINICAL DENSITOMETRY, 2015, 18 (02) : 150 - 156
  • [34] Cost-effectiveness of alendronate for the treatment of patients with low BMD and no prior fracture in Australia
    Defina, J
    Crowley, SJ
    Dalton, A
    Sen, SS
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S45 - S45
  • [35] Therapies for treatment of osteoporosis in US women: Cost-effectiveness and budget impact considerations
    Tosteson, Anna N. A.
    Burge, Russel T.
    Marshall, Deborah A.
    Lindsay, Robert
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (09): : 605 - 615
  • [36] The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
    Zethraeus, N.
    Strom, O.
    Borgstrom, F.
    Kanis, J. A.
    Jonsson, B.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (06) : 819 - 827
  • [37] The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
    N. Zethraeus
    O. Ström
    F. Borgström
    J. A. Kanis
    B. Jönsson
    Osteoporosis International, 2008, 19 : 819 - 827
  • [38] Cost-effectiveness of Ibandronate injection in the treatment of US women with postmenopausal osteoporosis.
    Earnshaw, Stephanie R.
    Graham, Christopher N.
    Amonkar, Mayur M.
    Barr, Charles E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S584 - S584
  • [39] COST-EFFECTIVENESS ANALYSES OF SCREENING AND TREATMENT STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS IN CHINESE WOMEN
    Si, L.
    Winzenberg, T. M.
    Wang, L.
    Palmer, A. J.
    VALUE IN HEALTH, 2014, 17 (07) : A773 - A773
  • [40] Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture
    L. Jacob
    M. Dreher
    K. Kostev
    P. Hadji
    Osteoporosis International, 2016, 27 : 963 - 969